The nationwide seven-day incidence of new corona infections has fallen again.

As the Robert Koch Institute (RKI) announced on Thursday morning, the value is now 1015.7.

The day before it was 1044.7, a week ago it was 1251.3.

The value quantifies the number of new infections per 100,000 inhabitants over a period of seven days.

As the RKI announced, citing data from the health authorities, the number of new infections reported within 24 hours on Thursday was 165,368 – after 176,303 the day before and 201,729 new infections a week ago.

The total number of registered cases of infection in Germany since the beginning of the corona pandemic has increased to 23,182,447.

According to the RKI, 310 other deaths related to the corona virus were also registered within 24 hours.

The total number of corona deaths recorded in Germany rose to 132,688.

Around 13.7 billion vaccine doses produced worldwide

According to the pharmaceutical association IFPMA, there are now more corona vaccine doses available worldwide than can be administered.

"The vaccine supply currently exceeds the demand," said IFPMA Director General Thomas Cueni in Geneva.

Since the start of production towards the end of 2020, around 13.7 billion vaccine doses have been manufactured and around eleven billion have been administered.

A total of almost eight billion vaccine doses could be produced this year, said Cueni.

Still, not all people who needed it would be vaccinated.

This is not due to the lack of vaccine doses - as was the case until late summer 2021 - but to the fact that the vaccination programs in some countries have not fully started.

This must be better organized in the event of possible new pandemics.

Cueni and the bosses of the pharmaceutical companies Pfizer, Albert Bourla, Roche Pharmaceuticals, Bill Anderson and Eli Lilly, David A. Ricks criticized ongoing calls to suspend patents on Covid-19 vaccines or drugs.

The investments that led to the rapid development of vaccines and medicines were only possible over the years thanks to patent protection.

Pfizer, together with the Mainz-based company Biontech, launched the world's first corona vaccine in December 2020.

Pfizer boss Bourla hopes to have a new corona vaccine by autumn that works equally well against all virus variants.

The aim is also to develop a vaccine that, like influenza, protects against severe disease progression and infection for a year.